Learn Chess with Dr. Wolf

About Learn Chess with Dr. Wolf

Player propositions were included in 65% of Bet Builders, up from 25% in 2022. Meanwhile, player shots on target became Kambi’s second-largest pre-match betting offer by turnover, while other popular selections included a player to score or assist.

“Customers seek personalised experiences, extensive player proposition bets and the ability to build highly customised wagers in real time,” Lamb says. “Meeting these modern expectations through manual trading is no longer realistic at scale.”

AI also helped Kambi reduce the delay between a customer selecting an in-play bet and being able to place it. Its dynamic live delay technology enables it to set bespoke live delay on an individual bet level, optimising the UX and alleviating friction. Across the Premier League and World Cup, Kambi reduced live betting delay by more than 40% between August 2025 and July 2026.

About Learn Chess with Dr. Wolf

Lottomatica will absorb Cirsa though an EU cross-border statutory merger, with Lottomatica continuing as the surviving entity.

Once the deal is completed, current Lottomatica shareholders are expected to own around 67.5% of the share capital, with Cirsa’s shareholders owning the remaining 32.5%.

Cirsa shareholders will receive 0.668 newly issued Lottomatica shares for each of their shares in Cirsa.

What is Learn Chess with Dr. Wolf?

With ice hockey and UFC-themed initiatives driving engagement in North America and a 45% lifetime value increase seen with the launch of MEGA Shoot, a player-versus-player simulation penalty shootout game initiative which launched during the World Cup, it is an exciting time for the Malta-based platform provider.

Barrett also describes how MEGA can “make a player feel connected within the software ecosystem and the brands” Soft2Bet operate with.

Play the video above to watch the full video interview and hear more insights from Harrison Barrett.